Thanks for not posting RX weeklies

[Anonymous]

That's his name

 

[Anonymous]

Dwight is OP

 

[Anonymous]

Rxs are UP this week! Keep it going gang!!

 

[Anonymous]

We are making headway!! We need to continue to step it up!!
"the prescription data for the week ending June 12, showed a drop in new prescriptions for Harvoni compared to the previous week. RBC’s Yee and Chung forecast full year sales for Harvoni and Sovaldi in 2015 at $11.7 billion, a smidge below consensus estimates.Total prescription written for Harvoni rose 2% to 9,133, while new prescription fell 1% to 3,317. Add Sovalidi, and total prescriptions for the two drugs rose 3% to 10,951, while new prescriptions remained flat"
Sincerely, The Wolfman AROOH! AROOOH! AROOOOH!

 

[Anonymous]

You're loosing the battle. Gilead will have the lions share. Merck and BMS will enter the market. ABBV will be gasping it's last breath in HCV. This is the picture most analysts are painting. Better hope someone pulls a miracle out of their ass! Ricky and the management team really are a C class management team.

 

[Anonymous]

You're loosing the battle. Gilead will have the lions share. Merck and BMS will enter the market. ABBV will be gasping it's last breath in HCV. This is the picture most analysts are painting. Better hope someone pulls a miracle out of their ass! Ricky and the management team really are a C class management team.

Wrong. We are getting our second wind, you just wait.

 

[Anonymous]

Your telling me every Wall Street analyst is wrong. I doubt it. No one has you at more than 15% share short tterm. Long term less than 5% with new agents. Wake up and smell the coffee.

 

[Anonymous]

You're loosing the battle. Gilead will have the lions share. Merck and BMS will enter the market. ABBV will be gasping it's last breath in HCV. This is the picture most analysts are painting. Better hope someone pulls a miracle out of their ass! Ricky and the management team really are a C class management team.

Loosing ? Bawwww Hawwwww Dumb Shit !

 

[Anonymous]

Losing the battle sorry for the typo CP enforcer . Still smarter that than your CEO. I have a BS and Masters.! Hahahaha asshole.

 

[Anonymous]

Your telling me every Wall Street analyst is wrong. I doubt it. No one has you at more than 15% share short tterm. Long term less than 5% with new agents. Wake up and smell the coffee.

Answer this: why would our own sales data be wrong? We actually make the product! Get off loser!

 

[Anonymous]

Losing the battle sorry for the typo CP enforcer . Still smarter that than your CEO. I have a BS and Masters.! Hahahaha asshole.

What you got is no life, no brains, and obviously no woman and no friends no family

 

[Anonymous]

Don't worry you still have CP, Sad So Sad !

 

[Anonymous]

Answer this: why would our own sales data be wrong? We actually make the product! Get off loser!

Your failure to really understand the market and future dynamics tells me that you are very misinformed and misleading. You're saying Wall Street has it wrong. We will see. I bet not the big money. If your a father have a nice fathers day. I will be out for a nice boat ride today with my family.

 

[Anonymous]

Your failure to really understand the market and future dynamics tells me that you are very misinformed and misleading. You're saying Wall Street has it wrong. We will see. I bet not the big money. If your a father have a nice fathers day. I will be out for a nice boat ride today with my family.

Thanks same to you. Oh and by the way, I'll be on my boat as many days as possible this summer while Abbvie is paying me.

 

[Richard Nixon]

Re: Thanks for not posting RX twinkies

Twinkies rule!

We need more twinkies

 

[Anonymous]

Symphony VPak numbers for w/e 6/12; TRx@ 863 & NRx@ 465
TRx is -10% compared to its high 955 reported w/e 5/22
NRx is -13% compared to its high 536 reported w/e 4/3

Gilead Benchmark
Symphony Harvoni/Solvaldi numbers for w/e 6/12; TRx@ 11,886 & NRx@ 5,037

BE INSPIRED VPak TEAM... WERE GETTING CLOSER TO THE 51% TARGET !!!
AWESOME PROGRESS 6 MONTHS INTO LAUNCH....

 

[Anonymous]

Symphony VPak numbers for w/e 6/12; TRx@ 863 & NRx@ 465
TRx is -10% compared to its high 955 reported w/e 5/22
NRx is -13% compared to its high 536 reported w/e 4/3

Gilead Benchmark
Symphony Harvoni/Solvaldi numbers for w/e 6/12; TRx@ 11,886 & NRx@ 5,037

BE INSPIRED VPak TEAM... WERE GETTING CLOSER TO THE 51% TARGET !!!
AWESOME PROGRESS 6 MONTHS INTO LAUNCH....

Stop posting numbers. It's demotivational and against policy.

 

[Anonymous]

Symphony VPak numbers for w/e 6/12; TRx@ 863 & NRx@ 465
TRx is -10% compared to its high 955 reported w/e 5/22
NRx is -13% compared to its high 536 reported w/e 4/3

Gilead Benchmark
Symphony Harvoni/Solvaldi numbers for w/e 6/12; TRx@ 11,886 & NRx@ 5,037

BE INSPIRED VPak TEAM... WE'RE GETTING CLOSER TO THE 51% TARGET !!!
AWESOME PROGRESS 6 MONTHS INTO LAUNCH....

My DM provides them to us to help and motivate. It's reassuring that we continue to grow and are on track, just like Rick tells us.

 

[Anonymous]

Wrong. We are getting our second wind, you just wait.

Symphony VPak numbers for w/e 6/12; TRx@ 863 & NRx@ 465
TRx is -10% compared to its high 955 reported w/e 5/22
NRx is -13% compared to its high 536 reported w/e 4/3

Gilead Benchmark
Symphony Harvoni/Solvaldi numbers for w/e 6/12; TRx@ 11,886 & NRx@ 5,037

 

[Anonymous]

Stop posting numbers. It's demotivational and against policy.

No it's not. Public information. You can find it on over a dozen financial sites.